GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.16
Bid: 3.52
Ask: 4.80
Change: 0.16 (4.00%)
Spread: 1.28 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

Thu, 30th Nov 2023 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Ashtead Technology Holdings PLC, up 20% at 582.00 pence, 12-month range 281.00p-594.00p. The subsea equipment rental, serving the offshore energy sector, says it now expects 2023 results to be "comfortably ahead of its previous expectations". It also announces a GBP53.5 million deal to acquire ACE Winches, from that firm's founders Alfie and Valerie Cheyne. ACE offers lifting, pulling and deployment services, and will sit nicely with "Ashtead Technology's existing equipment and services portfolio", it says.

----------

AIM - LOSERS

----------

Proteome Sciences PLC, down 25% at 4.54p, 12-month range 3.15p-8.79p. The protein-focused drug development services provider cuts its revenue outlook for 2023 amid delays to projects. It expects its top line to shrink from 2022's GBP7.8 million. "As reported by many other life science technology providers, the company has experienced delays to projects, many of which have been postponed to 2024. The healthcare industry has faced a very challenging market environment this year, especially in the second half of the year," Proteome Sciences explains. Proteome adds that reduced revenue combined with its commitment to invest in a US lab, means its now expects to post a net loss for 2023. In 2022, the company posted a profit after tax of GBP1.3 million. Proteome says it expects its US laboratory to be operational in the coming weeks and is lining up first customer projects for this laboratory.

----------

Totally PLC, down 16% at 4.85p, 12-month range 4.80p-38.00p. A poor week for the stock continues and it looks likely to suffer a fourth-successive share price decline. On Tuesday, the healthcare services provider in UK and Ireland reported that it swung to a pretax loss of GBP1.9 million in the first half ended September 30, from a profit of GBP1.0 million the year prior. Revenue fell 21% to GBP55.8 million during the period, from GBP70.3 million a year ago, Totally said. The firm blamed a "crisis" faced by the UK NHS for the lower revenue, given the loss of its North West London contracts. Shares have fallen 48% so far this week and it hit this 12-month low on Thursday.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
30 Nov 2010 13:34

Small caps round-up: Tinci, Nasstar, 600 Group...

Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months. N

Read more
13 Jul 2010 09:30

UK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from

Read more
13 Jul 2010 08:03

Proteome Sciences Develops Two Alzheimer's Tests

LONDON (Dow Jones)--Diagnostics company Proteome Sciences PLC (PRM.LN) Tuesday said it developed two tests focused on aspects of Alzheimer's disease. The company, which specializes in identifying proteins that could be hallmarks of disease, said one of the tests measures levels of nine proteins

Read more
18 Jun 2010 07:25

Proteome Sciences: German Court To Hear Sanofi Case End July

LONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July

Read more
6 Jul 2009 07:17

Proteome seals Alzheimer's tie-up

Proteome Sciences has signed an exclusive license agreement with Millipore Corp to develop new products aimed at helping advance the study of Alzheimer's disease. The disease identification specialist says Millipore will develop Luminex bead-based multiplex immunoassays to measure Proteome Sciences

Read more
18 Jun 2009 08:08

Proteome extends loan facility

Revenue rose strongly at disease identification specialist Proteome Sciences last year but cash inflows have fallen short of expectations. Revenue in 2008 rose to £0.85m from £0.27m in 2007 while loss before tax narrowed to £4.8m from £5.5m the year before. Cash in hand at the end of 2008 stood at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.